Comparison of efficacy and safety of teneligliptin versus sitagliptin as add on to metformin in type 2 diabetes mellitus at a tertiary care hospital. International Journal of Research in Pharmacology & Pharmacotherapeutics, [S. l.], v. 6, n. 2, p. 208–217, 2021. DOI: 10.61096/ijrpp.v6.iss2.2017.208-217. Disponível em: https://www.ijrpp.com/ijrpp/article/view/175. Acesso em: 18 apr. 2026.